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with a high concentration of d-glucose showed enhanced actinEffect of insulin and heparin on glucose-induced vascular dam-
expression. Actin expression was blunted with the addition ofage in cell culture.
Background. Clinical trials have shown that tight glycemic insulin or heparin in the culture medium.
control reduces the risk of diabetic microvascular complica- Conclusions. These biological findings indicate the salutary
tions, namely retinopathy, nephropathy, and neuropathy. The effect of insulin or insulin and heparin in the mitigation of vascu-
mechanism of these microvascular complications is not yet fully lar disorganization caused by a high concentration of d-glucose.
elucidated. The present study describes the effect of different
concentrations of glucose on vascular endothelial cells (ECs)
and vascular smooth muscle cells (VSMCs) in cell culture. Our
objective was to shed some light through this biological study Diabetes mellitus has become a global scourge. Dia-on the mechanism and prevention of diabetic microvascular
betic end-stage renal disease (ESRD) is the cause ofcomplications.
Methods. ECs and VSMCs were treated with 5 mmol/L (90 50% or more of the world’s dialysis population and has
mg/dL) or 30 mmol/L (540 mg/dL) d-glucose or d-glucose plus imposed a severe economic burden on society. Diabetic
insulin or d-glucose plus insulin and heparin in culture. ECs
ESRD, which is frequently accompanied by retinopathywere studied with light microscopy (LM), scanning electron mi-
with blindness, hypertension, coronary artery disease,croscopy (SEM), and transmission electron microscopy (TEM)
for surface changes. The cultured ECs were treated with vimen- and peripheral gangrene with unilateral or bilateral am-
tin antibodies and VSMCs with actin antibodies for immuno- putation, devastates the lives of diabetic patients and
flourescence microscopy (IFM) study. Endothelin-1 (ET-1) assay
their families. The precise mechanisms of the diabeticwas done on ECs culture medium using enzyme-linked immuno-
vascular complications are not yet elucidated. However,sorbent assay (ELISA).
Results. LM, SEM, and TEM of ECs treated with a physio- the vascular endothelium appears to be the initial target
logical concentration (90 mg/dL) of d-glucose appeared the site of injury [1–3]. Treatment of diabetes has thus far
same as control. However, LM and SEM of ECs treated with
revolved around controlling hyperglycemia in order toa high concentration of d-glucose (540 mg/dL) showed pro-
prevent these complications. To that end, prospectivenounced intercellular gaps. This finding was further confirmed
by TEM study. These gaps were minimally or not at all discern- clinical trials have determined that tight glycemic control
ible when insulin, heparin, or a combination of both was added and concomitant tight blood pressure control signifi-
to the culture medium. IFM showed increased vimentin expres-
cantly reduce the risk of microvascular complicationssion with a high concentration of d-glucose. Vimentin expres-
[4–6]. Previous studies from our laboratory have shownsion was attenuated with the addition of insulin or heparin in
the medium and more markedly with combined insulin and that heparin, a common therapeutic agent, consistently
heparin. Significant correlations were obtained between glu- decreases blood pressure in hypertensive rat models [7],cose levels, vimentin expression, and ET-1 levels. The higher
reduces actin and vimentin expression in cultured endo-the glucose level, the higher is the ET-1 production and the
greater vimentin expression in ECs. Cultured VSMCs treated thelial cells (ECs), and makes endothelial surfaces ap-
pear smooth [8]. The present study was designed to inves-
tigate the effect of insulin, heparin, or a combination of
Key words: cell adhesion, diabetic vascular complications, d-glucose,
both on cultured EC surface changes, vimentin expres-endothelial cells.
sion, and endothelin-1 (ET-1) release after treatment
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Table 1. Treatment media for endothelial cell culture 24-hour interval, the cells were rinsed with phosphate-
buffered saline (PBS, pH 7.2) and fixed with 2% glutaral-(1) Culture medium (CM)
(2) 5 mmol/L (90 mg/dL) glucose 1 CM dehyde in 0.1 mol/L phosphate buffer followed by 1%
(3) 30 mmol/L (540 mg/dL) glucose 1 CM aqueous osmium tetroxide. The filters with the fixed cells(4) Heparin (100 U/mL) 1 CM
were rinsed in deionized water and allowed to air dry(5) Heparin (500 U/mL) 1 CM
(6) Insulin (10 U/100 mL) 1 CM overnight. The filters were then mounted on stubs, sput-
(7) Insulin (20 U/100 mL) 1 CM ter coated with gold/palladium, and examined with the(8) 5 mmol/L glucose 1 insulin (10 U/100 mL) 1 CM
Philips 500 scanning electron microscope. Pictures of the(9) 30 mmol/L glucose 1 insulin (20 U/100 mL) 1 CM
(10) 5 mmol/L glucose 1 heparin (100 U/mL) 1 CM cells were taken in random fashion.
(11) 30 mmol/L Glucose 1 heparin (500 U/mL) 1 CM
(12) 5 mmol/L Glucose 1 insulin (10 U/100 mL) 1 heparin (100 U/mL) Transmission electron microscopy
1 CM
(13) 30 mmol/L glucose 1 insulin (20 U/100 mL) 1 heparin (500 U/mL) For transmission electron microscopy (TEM), ECs
1 CM were incubated with the same experimental media that
Cells were grown in the culture media with treatments for 24 h intervals. were described in the Methods section entitled “Viabil-
ity.” After removal from the culture flasks, cohesive cell
pellets were formed by a brief spin in an Eppendorf
microfuge. The pellets were fixed in 0.1 mol/L phosphate-METHODS
buffered 2% glutaraldehyde followed by one-hour post-
Viability fixation in 1% aqueous osmium tetroxide, dehydrated
The ECV304 EC line CRL 1998 was obtained from in a graded series of acetones, and embedded in Medcast
American Type Culture Collection (ATCC, Rockville, Epon/Araldite (Pelco, Redding, CA, USA). Silver-to-
MD, USA) and grown in 25 cm2 flasks in Media 199 gold thin sections were obtained with a Diatome dia-
containing 10% fetal calf serum (FCS) and gentamicin mond knife, mounted on uncoated grids, double stained
(50 mg/mL; Sigma Chemical Co., St. Louis, MO, USA). with aqueous saturated uranyl acetate and Reynolds lead
They were incubated in this culture medium at 378C with citrate, and then examined with a Philips 400 transmis-
5% CO2 and 80% humidity for four to five days until sion electron microscope.
confluency was attained. The cells were then incubated
Immunoflourescence study of cytoskeletal elements inwith fresh culture medium containing d-glucose [5
ECs and vascular smooth muscle cellsmmol/L (90 mg/dL) or 30 mmol/L (540 mg/dL)], insulin
(10 or 20 U/100 mL), and heparin (100 or 500 U/mL). The CRL 1692 VSMC line was also obtained from
The scheme for this is shown in Table 1. The cells were ATCC. The cells were cultures on 16-well glass chamber
incubated for 24 to 72 hours and then removed from the slides at 2.0 3 103 cells/well in Medium 199 containing
culture flasks using a trypsin (0.25%)-ethylenediamine- 10% FCS with 50 mg/mL gentamicin solution. Cultures
tetraacetic acid (0.3%; EDTA) solution. Exclusion of were maintained at 378C with 5% CO2 and 80% humidity
trypan blue was used as the criterion for cell viability. until confluent. The cultures were then given fresh Me-
dium 199 containing 5 mmol/L (90 mg/dL) or 30 mmol/L
Osmolality studies (540 mg/dL) d-glucose, 10 or 20 U/100 mL insulin, 100
We questioned the osmotic stress of glucose on ECs. or 500 U/mL heparin, or combinations thereof as demon-
Therefore, we performed an osmolality study of the dif- strated earlier and shown in Table 1. Fresh media were
ferent combinations of media. We used 25% mannitol, provided every 24 hours. After incubation, slides were
a substance that has the same molecular weight as glu- washed twice with 2 mL PBS/0.5% Tween-20 for five
cose but does not enter the cell. Mannitol thus served minutes, aspirated, and then fixed with 100% methanol
as an experimental control for osmotic effect. The osmol- for one hour at room temperature. Slides were again
ality of glucose and mannitol was determined using a washed, aspirated, and incubated for 30 minutes at room
Fiske osmometer. temperature in a humidity chamber. The ECs were treated
with 1 mL of monoclonal antibody to mouse vimentin,
Scanning electron microscopy and vascular smooth muscle cells (VSMCs) were treated
For scanning electron microscopy (SEM) study, ECs with 1 mL of monoclonal antibody to rabbit actin (Zymed
were cultured directly on Falcon cell culture membrane Laboratories, San Francisco, CA, USA) diluted in the same
inserts (0.4 micron filters) in the Media 199 culture me- buffer as described previously in this article. The slides
dium and then treated with glucose, insulin, and heparin were again washed and stained with 1 mL of flourescein
as described previously in this article and as shown in isothiocyanate (FITC)-conjugated goat antimouse IgM
Table 1. This approach to culture allows the cells to (1:100; Zymed Laboratories) or FITC goat antimouse
assume a polar and therefore a more natural phenotype IgG (1:100; Sigma), respectively. These were incubated
for 30 minutes at room temperature in a humidity cham-than standard monolayers on glass or plastic. After the
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ber. The slides were washed again and cover slipped groups. A Fisher’s Least Significant Difference (Fischer’s
LSD) comparison procedure was done to verify the va-using buffered glycerin mount with 0.1% paraphenylene-
diamine and examined using immunoflourescence mi- lidity of the finding. A correlation coefficient was done
for vimentin expression and ET-1 levels.croscopy (IFM). Pictures were produced using an Op-
tronics video camera/Sony printer system. Additional
controls were carried out by staining with nonspecific
RESULTS
antibodies to IgM and IgG. Slides were examined and
Osmolalitypictures were taken without the knowledge of histo-
chemical treatment. Vimentin or actin expression was The osmolality of the media was found to be similar
in all experiments. Thus, osmotic stress does not seemassessed semiquantitatively on a scale from 0 to 41, in
which 0 5 none, 11 is the least, and 41 is the most. to have any effect on the overall findings.
Light microscopy studyEndothelin-1 assay
Endothelin cells were treated with d-glucose alone or Cells were consistently 97 to 99% viable. ECs treated
with the physiologic concentration of glucose (5 mmol/L,d-glucose 1 insulin, d-glucose 1 heparin or d-glucose 1
insulin 1 heparin for a period of 24 hours. The cultures 90 mg/dL) were confluent (Fig. 1A), similar to ECs in
Medium 199 containing 10% FCS. ECs treated with highwere maintained with 5% CO2 and 80% humidity. Fol-
lowing this incubation time, the cellular supernatant was concentration of d-glucose (30 mmol/L/L, 540 mg/dL)
showed loss of confluency and wide separation (Fig. 1B).collected and frozen at 2208C until extracted and as-
sayed for ET-1. The frozen supernatant of the cultured
SEM studycells was thawed in a 378C water bath. Meanwhile, Sep
Columns (Peninsula Laboratories, Belmont, CA, USA) The ECs treated with 30 mmol/L (540 mg/dL) d-glu-
cose showed pronounced intercellular gaps (Fig. 2A).were activated with 100% acetonitrile and washed three
times with 1% triflouroacetic acid (TFA). The samples When insulin was added to the medium along with a
high concentration of d-glucose, the confluency of thewere passed through the Sep Columns, and the absorbed
material was then washed three times with 1% TFA. ECs was almost fully restored (Fig. 2B). The cellular
confluency was similar, when ECs were treated with hep-The peptide was slowly eluted with 60% acetonitrile in
1% TFA. The eluent was evaporated to dryness in a arin and a high concentration of d-glucose (Fig. 2C). How-
ever, the endothelial surface was smoother with the com-Labconco Centrivap concentrator and frozen at 2808C
until assayed for ET-1 production. ET-1 production was bination treatment (insulin 1 heparin) than with either
alone. Thus, ECs treated with 30 mmol/L d-glucose alonemeasured by using an ET-1 enzyme-linked immunosor-
bent assay kit (ELISA; Peninsula Laboratories, Belmont, showed a mean intercellular gap area that was signifi-
cantly (P 5 0.0001) wider than when ECs were treatedCA, USA). Samples were reconstituted in the assay ma-
trix provided, and aliquots were taken in duplicate for with a high concentration of d-glucose 1 insulin or a high
concentration of d-glucose 1 both insulin and heparin.the assay. The quantity of ET-1 was calculated from a
standard curve of known concentrations of the peptides. The measurement of gap junctions is presented in Table
2. No difference in gap area was noted when ECs were
Measurement of intercellular gaps treated with 10% FCS, 5 mmol/L (90 mg/dL) d-glucose,
25% mannitol or 30 mmol/L d-glucose 1 insulin, 30A millimeter rule was superimposed over SEM prints
taken at 3640 from randomly selected fields. The com- mmol/L d-glucose 1 heparin, or 30 mmol/L d-glucose 1
insulin 1 heparin.bined images were captured via video camera and stored
in JAVA under separate files. Four sets of four prints
TEM studyeach from five adjacent cells were measured to determine
the area of the intercellular gaps. After storing these Endothelial cells treated with control medium (10%
FCS) show adhesion between the cells. The membranemeasurements in the data file of JAVA, the file was
copied to a spreadsheet in the QuattroPro program. Each is intact between the cells (Fig. 3A). These findings
are indistinguishable from ECs treated with 5 mmol/Lset of four measurements was averaged, and the four
averages were again averaged to yield a mean average d-glucose (Fig. 3B). ECs treated with 30 mmol/L d-glu-
cose show wide gaps between the cells similarly as infor intercellular gap area (mm) under control and experi-
mental conditions. Three separate observations were Figures 1B and 2A. The intercellular membrane is hardly
discernible, and the microvilli are mostly fragmented,made for each experimental protocol.
resulting in a loss of bridge between the cells (Fig. 3C).
Statistical analysis When ECs were treated with 30 mmol/L d-glucose 1
insulin (20 m/100 mL), normal microvilli bridging theAn analysis of variance (ANOVA) was conducted to
determine whether the gap junctions differ among the gaps between the cells are noted (Fig. 3D).
Mandal et al: Preventing glucose-induced vascular damage 2495
Fig. 1. Light microscopy of endothelial cells
exposed to physiologic and pathologic concen-
trations of glucose. (A) Endothelial cells (ECs)
that grew in the presence of physiologic (5
mmol/L, 90 mg/dL) concentrations of d-glucose
demonstrate confluency (3400). (B) Those
cells that are exposed to pathologic glucose
conditions (30 mmol/L, 540 mg/dL) show pro-
nounced intercellular gaps (3400).
IFM study mmol/L d-glucose 1 5.5 m/100 mL insulin 1 100 U/mL
heparin (Fig. 4G). Vimentin expression in ECs treatedVimentin expression in ECs was slight or none (0 to
with mannitol is identical to control or between control11) in control medium (10% FCS), in ECs treated with
and treatment with heparin, but less enhanced than that30 mmol/L mannitol, or ECs treated with heparin alone
by 5 mmol/L d-glucose. However, most pronounced re-(Fig. 4 A–C). Vimentin expression varied from 21 in
organization of vimentin expression was noted whenECs treated with 5 mmol/L d-glucose (Fig. 4D), 41 in
both insulin and heparin were added to the culture me-ECs treated with 30 mmol/L d-glucose (Fig. 4E), or 21
dium in the presence of a high concentration of d-glucosein ECs treated with 30 mmol/L d-glucose 1 5.5 U/100
mL insulin (Fig. 4F), or 0 to 11 in ECs treated with 30 (Fig. 4G). The VSMC actin expression was found to be
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Fig. 2. Scanning electron microscopy demonstrating the ability of hep-
arin and insulin to restore EC confluency. (A; 31250) Demonstrates
the intercellular gaps that form when ECs are exposed to pathologic
concentrations of glucose (30 mmol/L, 540 mg/dL). (B; 31250) Illus-
trates that cells treated with insulin (20 U/100 mL) in the presence
of high-glucose concentrations are able to maintain their intercellular
adhesions and confluency. (C; 31250) Shows that cells treated with
heparin (500 U/mL) demonstrate confluency similar to those of insulin-
treated cells, despite the presence of pathologic glucose concentrations.
Table 2. Measurement of intercellular gaps cal concentration of d-glucose. The ET-1 level was at
control level in ECs treated with 5 mmol/L d-glucose 1Group Treatment Measurement mm
insulin 1 heparin. Vimentin expression and ET-1 levelsA 30 mmol/L glucose 2.2
B 30 mmol/L glucose 1 insulin 0.715 in different treatment groups are presented in Table 3.
C 30 mmol/L glucose 1 insulin 1 heparin 0.750 The results show a highly significant relationship be-
Statistical significances are: A vs. B, P 5 0.0001; A vs. C, P 5 0.0001; B vs. C, tween glucose levels and ET-1 production and vimentin
P 5 0.8491. Data points within groups are P 5 0.5821.
expression (Spearman correlation r 5 0.98, P 5 0.0001).
The higher the glucose level, the higher is the ET-1
production and the greater is vimentin expression in
markedly enhanced (31 to 41) in the presence of a high vascular ECs.
concentration of d-glucose (Fig. 5A) compared with that
(01 to 11) in the presence of a physiological concentra-
DISCUSSIONtion of d-glucose (90 mg/dL). The actin expression was
This study shows that the presence of a high concentra-reduced toward normal levels (01 to 11), with the addi-
tion of d-glucose (30 mmol/L) in EC culture for 24 hourstion of insulin or heparin in the presence of high concen-
causes the appearance of large intercellular gaps be-tration of d-glucose (Fig. 5B).
tween the ECs, and thereby the cells anatomically appear
ET-1 to have no intercellular membrane and have lost intercel-
lular adhesion (Figs. 1B, 2A, and 3C). This effect isEndothelin-1 level ranged from 0.08 ng/mL in ECs
significantly attenuated with the addition of insulin, hep-treated with FCS (control) to 1.71 ng/mL after treatment
arin, or a combination of both in culture (Figs. 2 B, Cwith 5 mmol/L d-glucose. ET-1 was significantly (P ,
and 3D). Cells treated with a physiological concentration0.05) higher (7.73 ng/mL) in ECs treated with 30 mmol/L
d-glucose than control or ECs treated with a physiologi- of d-glucose showed no effect on endothelial membrane
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Fig. 3. Transmission electron microscopy study of ECs. (A) ECs treated with FCS (control) show complete adhesion between cells with intact
intercellular membrane (36500). (B) ECs treated with physiological concentration of glucose (5 mmol/L or 90 mg/dL) show no difference from
control study (36500). (C) ECs treated with pathological concentration of glucose (30 mmol/L or 540 mg/dL) show wide separation of the cells
(as in Figs. 1B and 2A) with complete loss of intercellular microvilli. Intercellular microvilli have disappeared or fragmented (36500). (D) ECs
treated with pathological concentration of glucose and insulin (20U/100 mL) show adequate intercellular microvilli and adhesion (36500).
and hence adhesion (Fig. 3B). A high concentration of thrombin-stimulated ET-1 mRNA expression parallel
with a decrease in ET-1 peptide release in a dose-depen-d-glucose also causes overexpression of vimentin in ECs
and actin in VSMCs. Both vimentin and actin expression dent manner [10]. We have previously reported that hep-
arin causes EC cytoskeletal reorganization, which is aare down-regulated with the addition of insulin, heparin,
or a combination of both in culture for 24 hours. In- potential mechanism for vascular relaxation [8]. Insulin
has a lesser effect in reducing glucose-induced vimentincreased vimentin expression is significantly correlated
with elevated ET-1 in culture medium in the presence expression than heparin, but it is as potent as heparin
in reducing actin expression (Fig. 5B). Thus, our studiesof a high concentration of d-glucose, suggesting a cause
and effect relationship. The addition of a low dose of indicate that a combination of insulin and heparin are
very effective in reducing cytoskeletal (actin 1 vimentin)heparin with low dose of insulin in the culture medium
decreased the ET-1 level to control level, and that was expression, which is up-regulated by a high concentration
of d-glucose.accompanied by pronounced reorganization of vimentin
expression. In this study, both insulin and heparin have We propose that this salutary effect of insulin 1 hepa-
rin could be secondary to attenuation of endothelial gapsshown to down-regulate actin expression in cultured
smooth muscle cells. In our previous studies, we have induced by a high concentration of d-glucose and, hence,
maintenance of normal intercellular adhesion and an in-shown that heparin markedly suppresses ET-1 release
in cultured rat aortic and human umbilical vein ECs tact endothelium. The latter is conducive to normal capil-
lary blood flow. Like us, other investigators have reported(HUVECs) [9, 10]. Furthermore, in cultured HUVECs,
heparin has been shown to suppress both basal and deleterious effect of a high concentration of d-glucose
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Fig. 4. Immunofluorescence microscopy showing the effect of insulin and/or heparin on vimentin expression induced by different glucose concentra-
tion. (A; control) ECs treated with FCS show slight vimentin expression (3400). (B) ECs treated with 30 mmol/L mannitol show vimentin expression
similar to control (3400). (C) ECs treated with heparin (10 U/mL) alone show attenuation of vimentin expression compared with control (3400).
(D) ECs treated with physiological concentration of glucose (90 mg/dL) show 21 vimentin expression and slight reorganization appearing as
vesicles (3400). (E ) ECs treated with a high concentration of glucose (540 mg/dL) show a 41 increase in vimentin expression. No reorganization
or vesicle is evident (3400). (F ) ECs treated with high concentration of glucose and heparin show good reorganization giving rise to vesicle-like
appearances (3400). (G) ECs treated with a high concentration of glucose (540 mg/dL) and insulin and heparin show marked reorganization of
vimentin expression giving rise to pronounced vesiculation appearances (3400).
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Table 3. Relation between glucose levels, vimentin expression, and
endothelin-1 (ET-1) levels in cultured endothelial cells
ET-1
Treatment groups Vimentin ng/mL
Control media 0 0.0860.042
5 mmol/L G 2 1.7160.150
30 mmol/L G 4 7.7360.611
1 U/100 mL I 1 1.5560.154
5.5 U/100 mL I 3 4.5060.794
5 mmol/L G 1 1 U/100 mL I 1
100 U/mL H 1 0.3960.085
30 mmol/L G 1 5.5 U/100 mL I 1
100 U/mL H 3 5.5560.636
Data are mean 6 SD. Abbreviations are: G, glucose; I, insulin; H, heparin.
(25 mmol/L to 30 mmol/L) on ECs and VSMCs [11–14].
Fig. 4. (Continued). Graier et al have reported that d-glucose–induced changes
in cell proliferation of endothelial and smooth muscle
cells are related to d-glucose uptake rather than hyperos-
molality [11]. These authors have found that 5 and 44
mmol/L d-mannitol failed to affect EC proliferation. Also,
5 mmol/L as well as 44 mmol/L l-glucose had no effect on
endothelial proliferation [11]. Another study has shown
that decreasing the variability of blood glucose concen-
tration between 5 mmol/L and 25 mmol/L may decrease
the adverse effect of elevated glucose levels on mesangial
cell matrix production and the progression of diabetic
nephropathy [12]. Other studies have examined the role
of protein kinase C (PKC) in fibronectin expression and
diabetic nephropathy. Since a high concentration of glu-
cose has been shown to cause fibronectin overexpression
[13], the results are somewhat conflicting [14].
The deleterious effect of hyperglycemia may be medi-
ated by increased release of ET-1, as shown in this study.
Likewise, other investigators have noted that ET-1 con-
tent increased linearly in the culture medium with time
by increasing the concentration of glucose from 5.5 to
22.2 mmol/L (99 to 400 mg/dL) [15]. A simple increase
of osmotic tension by inclusion of 16.7 mmol/L mannitol
in the medium containing low concentration of glucose
(5.5 mmol/L) did not affect the ET-1 release. The addi-
tion of an aldose reductase inhibitor (statil) in the me-
dium containing a high concentration of glucose (22.5
mmol/L) did not suppress ET-1 production [16]. Thus,
increased release of ET-1 in the hyperglycemic state may
be caused by PKC-dependent pathway [17]. Still other
studies have shown that insulin treatment that achieves
euglycemia can prevent the increase in PKC activities
and diacylglycerol [18]. Since we have no data in PKC
activity, we are unable to elaborate on that. There are
reports that indicate that a high dose of insulin increases
the ET-1 level in cultured ECs [15, 19]. For instance,Fig. 5. Immunoflourescence studies of actin concentration in vascular
smooth muscle cells (VSMCs). (A) A high-glucose concentration (30 insulin at 1029 or 1028 mmol/L for 4, 8, and 24 hours
mmol/L) promotes increased expression of actin (41) in cultured stimulated ET-1 production in HUVEC culture [19]. Wesmooth muscle cells (3400). (B) Insulin is able to reduce the actin
expression in smooth muscle cells toward normal levels (11; 3400). have observed that 5.5 U/100 mL insulin increased the
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1 in NIDDM patients with and without microangiopathy. DiabetesET-1 level threefold higher than 1 U/100 mL insulin
Res Clin Pract 24:125–129, 1994
(Table 3). 3. Curcio A, Ceriello A: Decreased cultured endothelial cell prolif-
eration in high glucose medium is reversed by antioxidants: NewData are scarce on the effect of insulin on cytoskeletal
insights on the pathophysiologic mechanisms of diabetic vascularstructures and how insulin may mitigate diabetic ne-
complications. In Vitro Cell Dev Biol 28A:787–790, 1992
phropathy. However, the novel findings in our study 4. The Diabetes Control Complications Trial Research Group:
Effect of intensive therapy on residual B-cell function in patientswould confer that insulin might do so by maintaining
with type 1 diabetes in the diabetes control and complications trial.euglycemia and consequently adding to the salutary ef-
Ann Intern Med 128:517–523, 1998
fect of heparin in maintaining intercellular adhesion and 5. UK Prospective Diabetics Study Group: Intensive blood-glucose
control with sulphonylureas or insulin compared with conventionalcausing reorganization of cytoskeletal structures.
treatment and risk of complications in patients with type 2 diabetesSeveral studies including our own are consistent in
(UKPDS 38). Lancet 352:837–853, 1998
regard to the potential benefit of heparin pathophysio- 6. UK Prospective Diabetes Study Group: Tight blood pressure
control and risk of macrovascular and microvascular complicationslogically and therapeutically in the treatment of diabetes.
in type 2 diabetes: UKPDS 38. Br Med J 317:703–713, 1998Physiologically, heparan sulfate (HS) has been shown to
7. Mandal AK, Lyden TW, Saklayen MG: Heparin lowers blood
be important in the maintenance of glomerular size and pressure: Biological and clinical perspectives. Kidney Int 47:1017–
1022, 1995charge barrier [20, 21]. Several investigators are in agree-
8. Mandal AK, Lyden TW, Fazel A, Saklayen MG, Mehrotra B,ment that a defect in HS or HS proteoglycan may be Mahling B, Taylor CA, Yokokawa K, Colvin RB: Heparin-
involved in diabetic nephropathy or proteinuria [22, 23]. induced endothelial cell cytoskeletal reorganization: A potential
mechanism for vascular relaxation. Kidney Int 48:1508–1516, 1995A recent study has shown decreased HS in the urine
9. Yokokawa K, Mandal AK, Kohno M, Horio T, Murakawa K,of diabetic nephropathy, more so in those with overt Yasunari K, Takeda T: Heparin suppresses endothelin-1 action
nephropathy [24]. Finally, subcutaneous injection of un- and production in spontaneously hypertensive rats. Am J Physiol
263:R1035–R1041, 1992fractionated heparin or low molecular weight heparin
10. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawahas been shown to induce a significant reduction of pro- M, Takeda T: Heparin regulates endothelin production through
teinuria in diabetic nephropathy [25]. endothelium-derived nitric oxide in human endothelial cells. J Clin
Invest 92:2080–2085, 1993A recent study has shown increased vimentin expres-
11. Graier WF, Grubnethal I, Dittrich P, Wuscher TC, Kestnersion in the unclipped kidney in a one kidney-one clip GM: Intracellular mechanism of high d-glucose-induced modula-
model of hypertension and mitigation of both hyperten- tion of vascular proliferation. Eur J Pharmacol 294:221–229, 1995
12. Takeuchi A, Throckmorton DC, Brogden AP, Yoshizawa N,sion and vimentin expression by the use of angiotensin-
Rasmussen H, Kashgarian M: Periodic high extracellular glucoseconverting enzyme inhibitor (ACEI) or receptor blocker enhances production of collagens III and IV by mesangial cells.
[26]. We have previously reported that heparin signifi- Am J Physiol 268:F13–F19, 1995
13. Mueller HK, Fritsche U, Haslinger A, Landgraf R: Glucose-cantly reduces blood pressure in one kidney one-clip
filled fibronectin expression in endothelial cells is medicated by
model of hypertension [27]. We have further shown that protein kinase C. Exp Clin Endocrinol Diabetes 105:32–38, 1997
14. Cosio F: Effects of high glucose concentrations on human mesan-the effect of heparin is additive to ACEI in markedly
gial cell proliferation. J Am Soc Nephrol 5:1600–1609, 1995reducing blood pressure in the spontaneously hyperten-
15. Metsarinne K, Saijonmaa O, Yki-Jarvinen H, Fyhrquist F: Insu-
sive rat [28]. lin increases the release of endothelin in endothelial cell cultures
in vitro but not in vivo. Metabolism 43:878–882, 1994In summary, this study presents innovative data that
16. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H:are relevant for the mechanisms of diabetic microvascu-
Enhanced secretion of endothelin-1 by elevated glucose levels from
lar complications. Our biological findings are in agree- cultured bovine endothelial cell. FEBS Lett 267:16–18, 1990
17. Imai T, Hirata Y, Emori T, Marumo F: Heparin has an inhibitoryment with the clinical trials and further substantiate the
effect on endothelin-1 synthesis and release by endothelial cells.need for tight glycemic control and concomitantly ade-
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